Travere Therapeutics Announces Planned Chief Executive Officer Transition
Go back to Travere Therapeutics Announces Planned Chief Executive Officer Transition| (NASDAQ: TVTX) | Delayed: 59.65 -0.63 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.28 | 52 Week High | $ | |||
| Open | $60.39 | 52 Week Low | $ | |||
| Day High | $60.89 | P/E | N/A | |||
| Day Low | $58.32 | EPS | $ | |||
| Volume | 945,085 | |||||

